LungLife AI Statistics

Total Valuation

LungLife AI has a market cap or net worth of GBP 689,819. The enterprise value is -1.22 million.

Market Cap	689,819
Enterprise Value	-1.22M

Important Dates

The next estimated earnings date is Thursday, May 22, 2025.

Earnings Date	May 22, 2025
Ex-Dividend Date	n/a

Share Statistics

LungLife AI has 30.66 million shares outstanding. The number of shares has increased by 5.67% in one year.

Current Share Class	n/a
Shares Outstanding	30.66M
Shares Change (YoY)	+5.67%
Shares Change (QoQ)	+11.33%
Owned by Insiders (%)	26.15%
Owned by Institutions (%)	42.94%
Float	17.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	30.06
PB Ratio	0.11
P/TBV Ratio	0.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.34
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.35

Financial Position

The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.03.

Current Ratio	2.83
Quick Ratio	2.67
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.05
Interest Coverage	-140.09

Financial Efficiency

Return on equity (ROE) is -48.59% and return on invested capital (ROIC) is -30.30%.

Return on Equity (ROE)	-48.59%
Return on Assets (ROA)	-27.28%
Return on Invested Capital (ROIC)	-30.30%
Return on Capital Employed (ROCE)	-57.70%
Revenue Per Employee	2,868
Profits Per Employee	-441,825
Employee Count	15
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.46% in the last 52 weeks. The beta is -0.13, so LungLife AI's price volatility has been lower than the market average.

Beta (5Y)	-0.13
52-Week Price Change	-92.46%
50-Day Moving Average	1.41
200-Day Moving Average	8.02
Relative Strength Index (RSI)	60.20
Average Volume (20 Days)	771,005

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LungLife AI had revenue of GBP 22,947 and -3.53 million in losses. Loss per share was -0.13.

Revenue	22,947
Gross Profit	22,947
Operating Income	-3.66M
Pretax Income	-3.53M
Net Income	-3.53M
EBITDA	-3.45M
EBIT	-3.66M
Loss Per Share	-0.13

Full Income Statement

Balance Sheet

The company has 2.07 million in cash and 166,958 in debt, giving a net cash position of 1.91 million or 0.06 per share.

Cash & Cash Equivalents	2.07M
Total Debt	166,958
Net Cash	1.91M
Net Cash Per Share	0.06
Equity (Book Value)	6.28M
Book Value Per Share	0.22
Working Capital	1.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.37 million and capital expenditures -60,928, giving a free cash flow of -3.43 million.

Operating Cash Flow	-3.37M
Capital Expenditures	-60,928
Free Cash Flow	-3.43M
FCF Per Share	-0.11

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-15,941.26%
Pretax Margin	-15,389.54%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LungLife AI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.67%
Shareholder Yield	-5.67%
Earnings Yield	-512.40%
FCF Yield	-497.94%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LungLife AI has an Altman Z-Score of -5.25. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.25
Piotroski F-Score	n/a